Quick Answer
Benitec Biopharma Inc. reported Stockholders Equity of $97.30 million for fiscal year 2025.
Benitec Biopharma Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $97.30M | +105.9% |
| 2024 | $47.25M | +23290.1% |
| 2023 | $202.0K | -93.0% |
| 2022 | $2.88M | -85.6% |
| 2021 | $20.01M | +95.4% |
| 2020 | $10.24M | -38.3% |
| 2019 | $16.59M | +19.9% |
| 2018 | $13.84M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $187.36M | +146.7% | +100.2% |
| September 30, 2025 | $93.60M | +45.8% | -3.8% |
| June 30, 2025 | $97.30M | +105.9% | -0.3% |
| March 31, 2025 | $97.57M | +748.4% | +28.5% |
| December 31, 2024 | $75.94M | +390.9% | +18.3% |
| September 30, 2024 | $64.18M | +187.7% | +35.8% |
| June 30, 2024 | $47.25M | +23290.1% | +310.9% |
| March 31, 2024 | $11.50M | +144.0% | -25.7% |
- Benitec Biopharma Inc. showed an increase of +105.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Benitec Biopharma Inc.’s stockholders equity has grown by 602.8% (from $13.84 million to $97.30 million).
- The most recent figure is from Benitec Biopharma Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: